| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/22/2012 | EP1608767B1 Optimized expression of hpv 31 l1 in yeast |
| 02/22/2012 | EP1575531B9 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 02/22/2012 | CN1913921B 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法 By targeting the apoptotic expose internal antigens of tumor cells to kill tumor cells of the |
| 02/22/2012 | CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method |
| 02/21/2012 | US8119808 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 02/21/2012 | US8119787 Molecular tools for manufacturing anti-CD33 antibodies and fragments |
| 02/21/2012 | US8119680 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom |
| 02/21/2012 | CA2540170C Stabilized formulations of phosphatidylserine |
| 02/16/2012 | US20120041073 Stabilized mutant opsin proteins |
| 02/16/2012 | US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan |
| 02/16/2012 | US20120040921 Compositions and products containing s-equol, and methods for their making |
| 02/15/2012 | EP1633695B1 Smooth muscle spasmolytic agents |
| 02/15/2012 | CN102349927A Combination methods of treating cancer |
| 02/15/2012 | CN102349914A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/14/2012 | US8115027 NPY Y5 antagonist |
| 02/14/2012 | US8114972 Tumor and infectious disease therapeutic compositions |
| 02/14/2012 | US8114909 Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 02/14/2012 | US8114885 Chemical compounds |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/09/2012 | US20120035248 Method for inhibiting the activity of mir-155 |
| 02/09/2012 | US20120035073 Compositions and methods for the treatment of immune related diseases |
| 02/09/2012 | US20120034625 Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1 |
| 02/08/2012 | EP2415760A2 CCR-9 antagonists |
| 02/08/2012 | EP2415736A2 Anionic vinyl/dicarboxylic acid polymers and uses thereof |
| 02/08/2012 | EP2415486A2 Conjugates and compositions for cellular delivery |
| 02/08/2012 | EP1682074B1 Compositions and methods for healthy pregnancy |
| 02/08/2012 | CN1758900B 药物组合物 The pharmaceutical composition of |
| 02/07/2012 | US8110674 Therapeutic compositions |
| 02/07/2012 | US8110558 Oligomeric compounds and compositions for use in modulation of small non-coding RNAS |
| 02/07/2012 | US8110399 Isolating nestin-positive stem cells, expanding and translplanting into a patient to replace lost or damaged insulin secreting cells; differentiating pancreatic stem cells to obtain cells that produce insulin and other hormones |
| 02/07/2012 | CA2522295C Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 02/07/2012 | CA2460655C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 02/02/2012 | US20120029181 Synthesis of 5-azacytidine |
| 02/02/2012 | US20120029020 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/02/2012 | US20120029019 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/02/2012 | US20120027791 Antisense compound for inducing immunological tolerance |
| 02/01/2012 | EP1663262B1 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 02/01/2012 | EP1654231B1 Conjugate compounds and methods for reducing the risk of epileptic occurrence or for treatment of seizure disorders |
| 02/01/2012 | EP1572154B1 Medical devices employing novel polymers |
| 02/01/2012 | CN1742731B 治疗雌性性机能障碍的吡唑并嘧啶酮类 Treatment of female sexual dysfunction Pyrazolopyrimidine ketones |
| 01/31/2012 | US8106197 Aminoheteroaryl compounds as protein kinase inhibitors |
| 01/31/2012 | US8106025 Method for inhibiting the activity of mir-155 |
| 01/31/2012 | US8105793 Process for in vivo treatment of specific biological targets in bodily fluids |
| 01/31/2012 | US8105597 Aβ binding molecules |
| 01/31/2012 | US8105568 Vitamin receptor binding drug delivery conjugates |
| 01/26/2012 | US20120022106 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/26/2012 | US20120022065 C-Met Modulators and Method of Use |
| 01/26/2012 | US20120022004 Treatment of t-cell mediated diseases |
| 01/26/2012 | US20120020917 Methods for accelerating wound healing by administration of adipokines |
| 01/25/2012 | EP2409704A2 c-Met modulators and methods of use |
| 01/25/2012 | EP2409681A1 Method for improving the aesthetic appearance of skin by enhancing the skin thickness |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101579 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/24/2012 | US8101201 Compositions comprising dietary fat complexer and methods for their use |
| 01/24/2012 | CA2526578C Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/24/2012 | CA2515426C Uses and formulations for transdermal or transmucosal application of active agents |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/19/2012 | US20120016123 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/19/2012 | US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence |
| 01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |
| 01/18/2012 | EP2407470A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| 01/18/2012 | EP1668120B1 Method for detecting cancer cells and monitoring cancer therapy |
| 01/18/2012 | EP1587924B2 Methods for site-directed mutagenesis and targeted randomization |
| 01/17/2012 | US8097606 Schizophrenia, Schizoaffective disorder, Obsessive-Compulsive disorder, Personality Disorders and Dissociative Disorders; 11 beta -(4-dimethylaminoethoxyphenyl)-17 alpha -propynyl-17 beta -hydroxy-4,9 estradien-3-one and 17 beta -hydroxy-17 alpha -19-(4-methylphenyl)androsta-4,9(11)-dien-3-one |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/12/2012 | US20120009161 Therapeutic retroviral vectors for gene therapy |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP1608399B1 Complex of sclerostin and noggin or chordin, and agents that modulate the formation of said complex |
| 01/11/2012 | EP1572121B1 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | CN1934448B Method for the prevention of malaria |
| 01/10/2012 | US8093256 Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 01/10/2012 | US8093211 Methods and pharmaceutical compositions for healing wounds |
| 01/10/2012 | CA2544035C Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines |
| 01/05/2012 | US20120004189 Compositions and products containing s-equol, and methods for their making |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003243 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/05/2012 | US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/04/2012 | EP1678096B1 Lpa receptor agonists and antagonists and methods of use |
| 01/04/2012 | EP1624847B1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 01/04/2012 | EP1620058B1 Composition for improving cognition and memory |
| 01/04/2012 | CN102302493A Methods to mobilize progenitor/stem cells |
| 01/03/2012 | US8088894 Methods and compositions for Mycoplasma pneumoniae exotoxins |
| 01/03/2012 | US8088823 Tuberculosis treatment using pleuromutilin derivatives |
| 01/03/2012 | US8088752 Methods for metabolic modulation |
| 01/03/2012 | US8088737 Treating a cancer, in particular breast cancer, that overexpresses Her-2 by administering an ADAM inhibitor; novel variants of ADAM15 and ADAM15; synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds |
| 01/03/2012 | US8088583 Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same |
| 01/03/2012 | US8088397 Human lymphocyte vaccine adjuvant |
| 01/03/2012 | CA2544720C The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 01/03/2012 | CA2537702C Methods for the treatment of endometriosis |
| 01/03/2012 | CA2499622C Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 01/03/2012 | CA2486712C Method of treating diabetes |
| 12/29/2011 | US20110319395 Pharmaceutical Formulation of Olanzapine |
| 12/29/2011 | US20110319368 Once daily formulations of tetracyclines |
| 12/28/2011 | EP1411918B1 Methods to mobilize progenitor/stem cells |
| 12/28/2011 | CN1774259B 治疗系统性红斑狼疮的肽的胃肠道外制剂 Parenteral preparations for treatment of systemic lupus erythematosus peptides |
| 12/28/2011 | CN102293746A 治疗性脂质体 Therapeutic liposomes |